-
Leerink Swann Lowers Sucampo Pharmaceuticals (SCMP) Valuation To $6 - $7
Tuesday, March 16, 2010 - 9:05amLeerink Swann analysts Gary Nachman and Andrew Finkelstein reiterated their Outperform rating for shares of Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) and lowered valuation of the company's shares to $6 - $7 per share. The analysts said that there were uncertainties in the Sucampo Pharmaceuticals...
Read More >> -
Valeant Pharmaceuticals International’s (VRX) Fourth-Quarter Review
Tuesday, February 23, 2010 - 9:06pmAnalysts Gary Nachman and Andrew Finkelstein at Leerink Swann have released a report reviewing the fourth-quarter results at Valeant Pharmaceuticals International (NYSE: VRX). The company has reported solid results for the fourth-quarter. The company reported revenue of $241 million for the...
Read More >>
Gary Nachman
From Benzinga's Newsdesk
- 07:55 AM Leap Wireless: Cricket Wireless to Offer iPhone on June 22
- 07:46 AM Costco Wholesale May Comparable Store Sales up 4%
- 07:42 AM From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- 07:41 AM PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- 07:38 AM President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- 7:36 AM UPDATE: May Challenger Job Cuts 61.9K vs 40.6K Prior
- 07:35 AM NV Energy Announces Appointments of New CFO and COO
- 07:34 AM UPDATE: Wunderlich Securities Upgrades Ubiquiti Networks to Buy on Valuation
- 07:34 AM Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
- 07:34 AM Financial Breakfast: Morning News Summary for May 31, 2012
- 07:34 AM UPDATE: DA Davidson Raises PT to $45 on Texas Capital Bancshares on Higher Mortgage Revenues
- 07:33 AM From Earlier: Velti Announces Purchase of Shares by Non-Executive Directors and Senior Employees
- 07:32 AM The Bon-Ton Stores, Inc. Announces May Sales +1.5%
- 07:31 AM Patagonia Signs Multiyear Renewal Agreement With Alliance Data's Epsilon For Database Marketing Services
- 07:31 AM Chelsea Therapeutics Reports Top-Line Results of Phase II Trial of CH-4051 in Rheumatoid Arthritis
Brain Trust
- UPDATE: Morgan Stanley Upgrades Altera Corporation to Overweight 2H12 Outlook
- UPDATE: Canaccord Upgrades Coinstar to Buy on Market Share Gains
- UPDATE: JP Morgan Upgrades OmniVision Technologies to Overweight on iPhone 5 Prospects
- Cosan Q4 Net Earnings Down 69%
- Leap Wireless: Cricket Wireless to Offer iPhone on June 22
- Costco Wholesale May Comparable Store Sales up 4%
- From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- NV Energy Announces Appointments of New CFO and COO
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- Why Einhorn Is Wrong About Apple
- 5 Small-Cap Short Ideas
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
